| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-03 | Brown Melinda | director | Award | 20,979 | — | — |
| 2026-06-03 | Frankel Stanley | director | Award | 20,979 | — | — |
| 2026-06-03 | Germano Geno J | director | Award | 20,979 | — | — |
| 2026-06-03 | Pire Shari Lisa | director | Award | 20,979 | — | — |
| 2026-06-03 | Buehler Kevin | director | Award | 20,979 | — | — |
| 2026-05-20 | Buehler Kevin | director | Option exercise | 21,000 | — | — |
| 2026-05-20 | Frankel Stanley | director | Option exercise | 21,000 | — | — |
| 2026-05-20 | Brown Melinda | director | Option exercise | 21,000 | — | — |
| 2026-05-20 | Pire Shari Lisa | director | Option exercise | 21,000 | — | — |
| 2026-05-20 | Germano Geno J | director | Option exercise | 21,000 | — | — |
| Filed | Form | Filer | Stake | Shares | |
|---|---|---|---|---|---|
| 2020-07-09 | SC | venBio Global Strategic Fund, L.P. | — | — | view → |
| 2020-06-24 | SC | venBio Global Strategic Fund, L.P. | — | — | view → |
| 2020-06-08 | SC | venBio Global Strategic Fund, L.P. | — | — | view → |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-07-02 | SCHEDULE 13D | Passage BIO, Inc. PASG | 21.00% | 673,759 | view → |
| 2025-12-29 | SCHEDULE | Neuphoria Therapeutics Inc. NEUP | 16.30% | 875,328 | view → |
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →